NCT02460146View on ClinicalTrials.gov

PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Acute Kidney Injury
Interventions
DRUG

CXA-10

CXA-10 (10-nitro-9(E)-octadec-9-enoic acid) is a specific isomer of nitrated oleic acid

OTHER

CXA-10 placebo

The placebo contains olive oil with BHT (0.08% to 0.10%).

Trial Locations (1)

49007

Jasper Clinical Research & Development, Inc., Kalamazoo

Sponsors

Lead Sponsor

Complexa, Inc.
All Listed Sponsors
lead

Complexa, Inc.

INDUSTRY